4//SEC Filing
BLAIR JAMES C 4
Accession 0000899243-19-022160
CIK 0001466301other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 9:49 PM ET
Size
8.9 KB
Accession
0000899243-19-022160
Insider Transaction Report
Form 4
BLAIR JAMES C
Director10% Owner
Transactions
- Purchase
Common Stock
2019-08-20$5.97/sh+20,000$119,400→ 20,000 total(indirect: By Spouse) - Purchase
Common Stock
2019-08-16$5.70/sh+20,000$114,000→ 33,439 total
Holdings
- 10,105(indirect: By Susan W. and James C. Blair Family LP.)
Common Stock
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.65 to $5.73. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.88 to $6.09. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The Reporting Person disclaims beneficial ownership of such shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose.
- [F4]The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Documents
Issuer
Clovis Oncology, Inc.
CIK 0001466301
Entity typeother
IncorporatedCA
Related Parties
1- filerCIK 0001024000
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 9:49 PM ET
- Size
- 8.9 KB